What We Do

We innovate to improve patient outcomes. A dedication to the patient has been part of our focus stemming from guidance from the Institutes founder, Paul I Terasaki. Dr. Terasaki’s innovation in the forms of the developing the micro lymphocytotoxicity test (a tissue typing tray), a means for transporting donor kidneys (Collins’ solution), and a solid-phase HLA antibody detection test, have all changed medicine and improved patients’ lives.

Read More